Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Patent
1995-02-17
1998-08-04
Saunders, David
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
4241541, 4241731, 4241781, 4241831, A61K 39395
Patent
active
057889660
ABSTRACT:
The present invention provides methods of treating a subject suffering from a disorder associated with elevated levels of VLA-1 which comprises administering to the subject a therapeutically effective amount of an antibody which specifically forms a complex with VLA-1, inhibits collagen binding to VLA-1, and is directed to the epitope to which antibody 1B3.1 (ATCC No. HB10536) is directed and a pharmaceutically acceptable carrier.
REFERENCES:
patent: 5045451 (1991-09-01), Uhr et al.
P.A. Ward et al, Therapeutic Immunology, 1, 165-171, 1994.
Bank Ilan
Chess Leonard
Saunders David
The Trustees of Columbia University in the City of New York
White John P.
LandOfFree
Antibody which is directed against and inhibits collagen binding does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibody which is directed against and inhibits collagen binding, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody which is directed against and inhibits collagen binding will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1174307